01 / Vendor Profile
RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH Federal Contracts and Awards
UEI JMW6R9VB27L9 · CAGE 5831N
Federal contract activity attributed to this vendor identity across FY 2019–FY 2025. Obligations are FPDS accounting transactions, not company revenue.
02 / Federal Business Size
Federal contract market at a glance
Measured consistently across FY 2019–FY 2025.
Across FY 2019–FY 2025, FPDS records attribute $2.09M in net contract obligations to RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH across 6 contract actions. Net obligations include positive obligations and later deobligations recorded during the same period.
03 / Spending Trend
RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH contract spending by year
Annual net obligations show whether recorded federal business expanded or contracted, while actions and customer counts show the breadth of that activity.
Total obligations$0
FY 2022ObligationsHistorical spending range
| Fiscal year | Obligations | Actions | Federal customers | Change |
|---|---|---|---|---|
| FY 2020 | $2.09M | 2 | 1 | — |
| FY 2021 | $0 | 1 | 1 | −100.0% |
| FY 2022 | $0 | 3 | 1 | — |
04 / Federal Customers
Which federal agencies buy from RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH?
Ranked by net obligations during FY 2019–FY 2025.
| Agency | Code | Obligations | Actions | Vendor share |
|---|---|---|---|---|
| 7524 | $2.09M | 6 | 100.0% |
05 / Contracting Offices
Which contracting offices buy from RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH?
Ranked by net obligations during FY 2019–FY 2025.
| Office | Code | Agency | Obligations | Actions | Vendor share |
|---|---|---|---|---|---|
| 75F401 | FOOD AND DRUG ADMINISTRATION | $2.09M | 6 | 100.0% |
06 / Top NAICS Industries
Which industries define this vendor’s federal work?
| NAICS | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| 541714 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | $2.09M | 6 | 1 | 100.0% |
07 / Top Product and Service Codes
What products and services does the government buy from this vendor?
08 / Competition Pattern
How was RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH’s federal work competed?
Competition categories describe the procurement path recorded on the underlying contract actions.
09 / Recent Contract Awards
What contract actions were recorded most recently for RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH?
The latest recorded PIIDs connect this profile to the underlying federal award search.
| Award / PIID | Signed | Obligation | Agency / office | NAICS | PSC |
|---|---|---|---|---|---|
| 75F40120C00070 | Jul 5, 2022 | $0 | FOOD AND DRUG ADMINISTRATION FDA OFFICE OF ACQ GRANT SVCS | 541714 | AN11 |
10 / Interpreting the Profile
How should you evaluate RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH as a federal contractor?
Read obligations, customers, markets, competition, and individual awards together. A large historical total indicates federal scale, but it does not by itself describe current backlog, commercial revenue, profitability, or future opportunity.
Separate obligations from revenue
FPDS obligations are government accounting actions and may include later deobligations.
Follow customer concentration
Agency and office concentration reveals where the vendor’s federal relationships are strongest.
Test market overlap
NAICS and PSC shares show whether the vendor competes in the same markets as your company.
Inspect the awards
Open the PIIDs to verify dates, offices, classifications, and transaction history.